-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Selgantolimod
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2004677-13-6.gif)
| Category | Human immunodeficiency Virus (HIV) |
| CAS | 2004677-13-6 |
| Description | Selgantolimod (GS-9688) is an orally active, potent and selective toll-like receptor 8 (TLR8) agonist for the treatment of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infection. |
Product Information
| Synonyms | Selgantolimod|2004677-13-6|GS-9688|(2R)-2-[(2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino]-2-methylhexan-1-ol|(R)-2-((2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino)-2-methylhexan-1-ol|Selgantolimod (USAN/INN)|CHEMBL4594258|SCHEMBL18109405|GTPL10889|EX-A4247|BDBM50559849|GS9688|HY-109137|compound (R)-7 [PMID: 32407112]|CS-0086927|D11871|U57 |
| Molecular Weight | 293.34 |
| Molecular Formula | C14H20FN5O |
| Canonical SMILES | CCCCC(C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N |
| Purity | 99.17% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Light yellow to yellow (Solid) |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| Complexity | 335 |
| Exact Mass | 293.16518844 |
| Target | Toll-like Receptor (TLR); HBV |
| XLogP3-AA | 2 |
